Table 1 Characteristics of studies included in the meta-analysis.
Author (year) | Study design | Participant ethnicity | Number of participant | HLA genotypes | |||
|---|---|---|---|---|---|---|---|
Case (n) | Control (n) | HLA-A genotypes | HLA-B genotypes | HLA-C genotypes | |||
Ueta et al. (2014)23 | Case control | Japanese | 151 (Group1 KPUM: n = 131; Group2 NIHS: n = 20) | 639 (Group1 KPUM: n = 419; Group2 NIHS: n = 220) | HLA-A*0206, HLA-A*0301, HLA-A*1101, HLA-A*2402 | HLA-B*1301, HLA-B*1501, HLA-B*4402, HLA-B*4403, HLA-B*4601, HLA-B*5201, HLA-B*5401 | HLA-C*0304, HLA-C*0501, HLA-C*1202 |
Ueta et al. (2014)24 | Case control | Indian | 20 | 55 | HLA-A*0206 | HLA-B* 4403 | HLA-C*0701 |
Brazilian | 39 (Ethnicity: Pardo, n = 19; White, n = 15; Black, n = 3; White/Indian, n = 1; White/Black/Indian, n = 1) | 134 (Ethnicity: Pardo, n = 66; White, n = 62; Black, n = 4, Indian/White, n = 2) | |||||
Korean | 31 | 90 | |||||
Kannabiran et al. (2017)33 | Case control | Indian | 80 | 50 | HLA-A*0101, HLA-A*0211, HLA-A*0301, HLA-A*1101, HLA-A*2402,HLA-A*2601, HLA-A*3201,HLA-A*3303, HLA-A*6801 | HLA-B*0705, HLA-B*1502, HLA-B*3501, HLA-B*3503, HLA-B*4006, HLA-B*4403, HLA-B*5101, HLA-B*5201, HLA-B*5701 | HLA-C*0102, HLA-C*0401, HLA-C*0602, HLA-C*0701, HLA-C*0702, HLA-C*0801, HLA-C*1202, HLA-C*1502 |
Wakamatsu et al. (2017)34 | Case control | Brazilian | 39 (Ethnicity: European, n = 16; Pardoa, n = 19) | 133 (Ethnicity: European, n = 61; Pardo, n = 66) | HLA-A*0101, HLA-A*0201, HLA-A*0202, HLA-A*0205, HLA-A*0206, HLA-A*0301, HLA-A*1101, HLA-A*2402, HLA-A*2601, HLA-A*2902, HLA-A*3001, HLA-A*3002, HLA-A*3101, HLA-A*3201, HLA-A*3303, HLA-A*3402, HLA-A*3601,HLA-A*6601, HLA-A*6801,HLA-A*6802, HLA-A*7401 | HLA-B*0702, HLA-B*0801, HLA-B*1302, HLA-B*1401, HLA-B*1510, HLA-B*1801, HLA-B*2705, HLA-B*3501, HLA-B*3502, HLA-B*3503, HLA-B*3508, HLA-B*3801, HLA-B*3903, HLA-B*4001, HLA-B*4002, HLA-B*4101, HLA-B*4201, HLA-B*4402, HLA-B*4405, HLA-B*4901, HLA-B*5001,HLA-B*5101, HLA-B*5201,HLA-B*5301, HLA-B*5501,HLA-B*5601, HLA-B*5701,HLA-B*5703, HLA-B*5801,HLA-B*5803 | HLA-C*0102, HLA-C*0202, HLA-C*0302, HLA-C*0303, HLA-C*0304, HLA-C*1203, HLA-C*0401, HLA-C*0501, HLA-C*0602, HLA-C*0701, HLA-C*0702, HLA-C*0704, HLA-C*0802, HLA-C*1203, HLA-C*1402, HLA-C*1502, HLA-C*1601, HLA-C*1701 |
Jongkhajornpong et al. (2018)35 | Case control | Thai | 71 | 119 | HLA-A*2402, HLA-A*3303 | HLA-B*2704, HLA-B*4401, HLA-B*4403 | HLA-C*0701 |
Jun et al. (2019)36 | Case control | Korean | 40 | 120 | HLA-A*0206 | HLA-C*0304, HLA-C*0503 | |
